Characteristic Distinctions Between Pre-/Post-COVID-19 Teledermatology Adoptees: A Cross-Sectional United States-based Analysis and the Implications for Dermatologic Healthcare Equity

January 2023 | Volume 22 | Issue 1 | 101 | Copyright © January 2023


Published online December 28, 2022

Justin W. Marson MDa, Maham Ahmad BAb, Graham H. Litchman DO MSc, Danny Zakria MD MBAd, Sara Perkins MDb, Darrell S. Rigel MD MSe

aDepartment of Dermatology, SUNY Downstate Health Sciences University, Brooklyn, NY
bDepartment of Dermatology, Yale University School of Medicine, New Haven, CT
cDepartment of Dermatology, St. John's Episcopal Hospital, Far Rockaway, NY
dNational Society for Cutaneous Medicine, New York, NY
eDepartment of Dermatology, Mt. Sinai Icahn School of Medicine, New York, NY

IRB approval status: Reviewed and granted exempt status by Advarra IRB; approval #Pro00060440



Data from 338 practicing US-based dermatologists were analyzed (Table 1). Academic/Government dermatologists were 4-times more likely (OR 4.08, 95%CI 2.37-7.03) to adopt teledermatology pre-COVID than private practice dermatologists. Dermatologists with ≤10 years of experience (YoE) were 1.8-times (OR 1.8, 95%CI 1.01-3.18) and 2.82-times more likely (OR 2.82, 95%CI 0.78-10.25) to adopt teledermatology pre-COVID-19 (ie, early-adopters (EAs)) or at all, respectively, compared to dermatologists with ≥20 YoE. No significant relationship existed between TAT and practice location (X2(14, n=338)=10.87, P=.70) even after stratification by US Census Bureau region, section codes (ie, first three digits in a given area code), or population density (ie, urban (≥50,000 persons/zip code) or rural (<50,000 person/zip code)).

Teledermatology-adopters practiced proportionally more medical-dermatology (P<.0001; Tukey-Kramer α<.05) than nonadopters (NAs), who reported proportionally more dermatologic